11-1840530-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003282.4(TNNI2):​c.60T>C​(p.Ser20Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.871 in 1,611,762 control chromosomes in the GnomAD database, including 613,286 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 52802 hom., cov: 36)
Exomes 𝑓: 0.88 ( 560484 hom. )

Consequence

TNNI2
NM_003282.4 splice_region, synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: -0.300

Publications

21 publications found
Variant links:
Genes affected
TNNI2 (HGNC:11946): (troponin I2, fast skeletal type) This gene encodes a fast-twitch skeletal muscle protein, a member of the troponin I gene family, and a component of the troponin complex including troponin T, troponin C and troponin I subunits. The troponin complex, along with tropomyosin, is responsible for the calcium-dependent regulation of striated muscle contraction. Mouse studies show that this component is also present in vascular smooth muscle and may play a role in regulation of smooth muscle function. In addition to muscle tissues, this protein is found in corneal epithelium, cartilage where it is an inhibitor of angiogenesis to inhibit tumor growth and metastasis, and mammary gland where it functions as a co-activator of estrogen receptor-related receptor alpha. This protein also suppresses tumor growth in human ovarian carcinoma. Mutations in this gene cause myopathy and distal arthrogryposis type 2B. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
TNNI2 Gene-Disease associations (from GenCC):
  • distal arthrogryposis type 2B1
    Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 11-1840530-T-C is Benign according to our data. Variant chr11-1840530-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.3 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.963 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNI2NM_003282.4 linkc.60T>C p.Ser20Ser splice_region_variant, synonymous_variant Exon 5 of 8 ENST00000381911.6 NP_003273.1
TNNI2NM_001145829.2 linkc.60T>C p.Ser20Ser splice_region_variant, synonymous_variant Exon 5 of 8 NP_001139301.1
TNNI2NM_001145841.2 linkc.60T>C p.Ser20Ser splice_region_variant, synonymous_variant Exon 3 of 6 NP_001139313.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNI2ENST00000381911.6 linkc.60T>C p.Ser20Ser splice_region_variant, synonymous_variant Exon 5 of 8 2 NM_003282.4 ENSP00000371336.1

Frequencies

GnomAD3 genomes
AF:
0.827
AC:
125656
AN:
152026
Hom.:
52761
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.666
Gnomad AMI
AF:
0.836
Gnomad AMR
AF:
0.875
Gnomad ASJ
AF:
0.864
Gnomad EAS
AF:
0.985
Gnomad SAS
AF:
0.878
Gnomad FIN
AF:
0.938
Gnomad MID
AF:
0.841
Gnomad NFE
AF:
0.877
Gnomad OTH
AF:
0.844
GnomAD2 exomes
AF:
0.879
AC:
214784
AN:
244286
AF XY:
0.880
show subpopulations
Gnomad AFR exome
AF:
0.652
Gnomad AMR exome
AF:
0.900
Gnomad ASJ exome
AF:
0.860
Gnomad EAS exome
AF:
0.988
Gnomad FIN exome
AF:
0.932
Gnomad NFE exome
AF:
0.878
Gnomad OTH exome
AF:
0.879
GnomAD4 exome
AF:
0.875
AC:
1277376
AN:
1459618
Hom.:
560484
Cov.:
106
AF XY:
0.876
AC XY:
636062
AN XY:
726092
show subpopulations
African (AFR)
AF:
0.652
AC:
21832
AN:
33466
American (AMR)
AF:
0.898
AC:
40105
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.856
AC:
22361
AN:
26108
East Asian (EAS)
AF:
0.992
AC:
39347
AN:
39674
South Asian (SAS)
AF:
0.877
AC:
75587
AN:
86222
European-Finnish (FIN)
AF:
0.936
AC:
48565
AN:
51912
Middle Eastern (MID)
AF:
0.841
AC:
4837
AN:
5752
European-Non Finnish (NFE)
AF:
0.875
AC:
972385
AN:
1111536
Other (OTH)
AF:
0.868
AC:
52357
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
11223
22446
33668
44891
56114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21290
42580
63870
85160
106450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.827
AC:
125752
AN:
152144
Hom.:
52802
Cov.:
36
AF XY:
0.832
AC XY:
61914
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.666
AC:
27598
AN:
41422
American (AMR)
AF:
0.876
AC:
13405
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.864
AC:
3000
AN:
3472
East Asian (EAS)
AF:
0.985
AC:
5095
AN:
5172
South Asian (SAS)
AF:
0.879
AC:
4244
AN:
4830
European-Finnish (FIN)
AF:
0.938
AC:
9972
AN:
10626
Middle Eastern (MID)
AF:
0.836
AC:
244
AN:
292
European-Non Finnish (NFE)
AF:
0.877
AC:
59643
AN:
67996
Other (OTH)
AF:
0.846
AC:
1789
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
1121
2243
3364
4486
5607
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.862
Hom.:
113031
Bravo
AF:
0.815
Asia WGS
AF:
0.928
AC:
3226
AN:
3478
EpiCase
AF:
0.876
EpiControl
AF:
0.869

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 25, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Distal arthrogryposis type 2B1 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1Other:1
-
TNNI2 homepage - Leiden Muscular Dystrophy pages
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Arthrogryposis multiplex congenita Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
6.9
DANN
Benign
0.55
PhyloP100
-0.30
PromoterAI
-0.0014
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs907610; hg19: chr11-1861760; COSMIC: COSV53290568; COSMIC: COSV53290568; API